1. Home
  2. ATOS vs MBOT Comparison

ATOS vs MBOT Comparison

Compare ATOS & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • MBOT
  • Stock Information
  • Founded
  • ATOS 2009
  • MBOT 2010
  • Country
  • ATOS United States
  • MBOT United States
  • Employees
  • ATOS N/A
  • MBOT N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • MBOT Medical/Dental Instruments
  • Sector
  • ATOS Health Care
  • MBOT Health Care
  • Exchange
  • ATOS Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • ATOS 112.5M
  • MBOT 99.3M
  • IPO Year
  • ATOS 2012
  • MBOT N/A
  • Fundamental
  • Price
  • ATOS $0.85
  • MBOT $2.64
  • Analyst Decision
  • ATOS Strong Buy
  • MBOT Strong Buy
  • Analyst Count
  • ATOS 3
  • MBOT 1
  • Target Price
  • ATOS $6.17
  • MBOT $9.00
  • AVG Volume (30 Days)
  • ATOS 1.5M
  • MBOT 1.3M
  • Earning Date
  • ATOS 08-11-2025
  • MBOT 08-13-2025
  • Dividend Yield
  • ATOS N/A
  • MBOT N/A
  • EPS Growth
  • ATOS N/A
  • MBOT N/A
  • EPS
  • ATOS N/A
  • MBOT N/A
  • Revenue
  • ATOS N/A
  • MBOT N/A
  • Revenue This Year
  • ATOS N/A
  • MBOT N/A
  • Revenue Next Year
  • ATOS N/A
  • MBOT N/A
  • P/E Ratio
  • ATOS N/A
  • MBOT N/A
  • Revenue Growth
  • ATOS N/A
  • MBOT N/A
  • 52 Week Low
  • ATOS $0.55
  • MBOT $0.82
  • 52 Week High
  • ATOS $1.66
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 51.17
  • MBOT 55.28
  • Support Level
  • ATOS $0.81
  • MBOT $2.43
  • Resistance Level
  • ATOS $0.92
  • MBOT $2.60
  • Average True Range (ATR)
  • ATOS 0.05
  • MBOT 0.13
  • MACD
  • ATOS -0.00
  • MBOT 0.01
  • Stochastic Oscillator
  • ATOS 52.73
  • MBOT 63.83

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: